AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie median Employee Annual Total Compensation ($) ($)
DEF 14A Proxy Statement Pay Ratio Disclosure
Latest, FY2025
169,019
Period ended Dec 31, 2025
Change on a year earlier
+25.8%
134,351 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Median Employee Annual Total Compensation ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 169,019 | +25.8% | Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23) ↗ |
| FY2024 | Dec 31, 2024 | 134,351 | -11.6% | Proxy Statement (DEF 14A) (abbv-20250509xdef14a.htm, filed 2025-03-24) ↗ |
| FY2023 | Dec 31, 2023 | 151,991 | +29.7% | Proxy Statement (DEF 14A) (abbv-20240503xdef14a.htm, filed 2024-03-18) ↗ |
| FY2022 | Dec 31, 2022 | 117,189 | -21.7% | Proxy Statement (DEF 14A) (abbv-20230505xdef14a.htm, filed 2023-03-20) ↗ |
| FY2021 | Dec 31, 2021 | 149,662 | -3.9% | Proxy Statement (DEF 14A) (tmb-20220506xdef14a.htm, filed 2022-03-21) ↗ |
| FY2020 | Dec 31, 2020 | 155,772 | -0.1% | Proxy Statement (DEF 14A) (tmb-20210507xdef14a.htm, filed 2021-03-22) ↗ |
| FY2019 | Dec 31, 2019 | 155,885 | – | Proxy Statement (DEF 14A) (a2241076zdef14a.htm, filed 2020-03-23) ↗ |
Cite this data
StockData. (2026). AbbVie Median Employee Annual Total Compensation ($) ($), annual FY2019–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/gov_median_emp_pay
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.